{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:32:47Z","timestamp":1783780367238,"version":"3.55.0"},"reference-count":17,"publisher":"Japanese Association of Virology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Uirusu"],"published-print":{"date-parts":[[2018]]},"DOI":"10.2222\/jsv.68.21","type":"journal-article","created":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T22:04:43Z","timestamp":1558130683000},"page":"21-30","source":"Crossref","is-referenced-by-count":2,"title":["Herpes Zoster Vaccine","\u5e2f\u72b6\u75b1\u75b9\u30ef\u30af\u30c1\u30f3"],"prefix":"10.2222","volume":"68","author":[{"given":"Daisuke","family":"WATANABE","sequence":"first","affiliation":[{"name":"Department of Dermatology, Aichi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1062","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"2) Toyama N, Shiraki K; Society of the Miyazaki Prefecture Dermatologists. Epidemiology of herpes zoster and its relationship to varicella in Japan: A 10-year survey of 48,388 herpes zoster cases in Miyazaki prefecture. J Med Virol 2009;81:2053-8.","DOI":"10.1002\/jmv.21599"},{"key":"2","doi-asserted-by":"crossref","unstructured":"3) Weinberg JM. Herpes zoster: epidemiology, natural history, and common complications. J Am Acad Dermatol. 2007;57:S130-5.","DOI":"10.1016\/j.jaad.2007.08.046"},{"key":"3","doi-asserted-by":"crossref","unstructured":"4) Hata A, Kuniyoshi M, Ohkusa Y. Risk of Herpes zoster in patients with underlying diseases: a retrospective hospital-based cohort study. Infection 2011;39:537-44.","DOI":"10.1007\/s15010-011-0162-0"},{"key":"4","doi-asserted-by":"crossref","unstructured":"5) Habel LA, Ray GT, Silverberg MJ, Horberg MA, Yawn BP, Castillo AL, Quesenberry CP Jr, Li Y, Sadier P, Tran TN. The epidemiology of herpes zoster in patients with newly diagnosed cancer. Cancer Epidemiol Biomarkers Prev 2013;22:82-90.","DOI":"10.1158\/1055-9965.EPI-12-0815"},{"key":"5","doi-asserted-by":"crossref","unstructured":"7) Imafuku S, Nakayama J, Higa K, Furue M, Takahara M, Katayama I, Tani M. One-year follow-up of zoster-associated pain in 764 immunocompetent patients with acute herpes zoster treated with famciclovir (FAMILIAR study). J Eur Acad Dermatol Venereol 2014; 28:1716-22.","DOI":"10.1111\/jdv.12379"},{"key":"6","doi-asserted-by":"crossref","unstructured":"9) Langan SM, Minassian C, Smeeth L, Thomas SL. Risk of stroke following herpes zoster: a self-controlled case-series study. Clin Infect Dis 2014;58:1497-503.","DOI":"10.1093\/cid\/ciu098"},{"key":"7","doi-asserted-by":"crossref","unstructured":"10) Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 1974;2:1288-90.","DOI":"10.1016\/S0140-6736(74)90144-5"},{"key":"8","doi-asserted-by":"crossref","unstructured":"12) Hales CM, Harpaz R, Joesoef MR, Bialek SR. Examination of links between herpes zoster incidence and childhood varicella vaccination. Ann Intern Med 2013;159:739-45.","DOI":"10.7326\/0003-4819-159-11-201312030-00006"},{"key":"9","doi-asserted-by":"crossref","unstructured":"13) Goldman GS, King PG. Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data. Vaccine. 2013; 31:1680-94.","DOI":"10.1016\/j.vaccine.2012.05.050"},{"key":"10","doi-asserted-by":"crossref","unstructured":"15) Okuno Y, Takao Y, Miyazaki Y, Ohnishi F, Okeda M, Yano S, Kumihashi H, Gomi Y, Maeda K, Ishikawa T, Mori Y, Asada H, Iso H, Yamanishi K; Shozu Herpes Zoster (SHEZ) Study Group. Assessment of skin test with varicella-zoster virus antigen for predicting the risk of herpes zoster. Epidemiol Infect 2013; 141:706-13.","DOI":"10.1017\/S0950268812002671"},{"key":"11","doi-asserted-by":"crossref","unstructured":"16) Asada H, Nagayama K, Okazaki A, Mori Y, Okuno Y, Takao Y, Miyazaki Y, Onishi F, Okeda M, Yano S, Kumihashi H, Gomi Y, Maeda K, Ishikawa T, Iso H, Yamanishi K; Shozu Herpes Zoster (SHEZ) Study group. An inverse correlation of VZV skin-test reaction, but not antibody, with severity of herpes zoster skin symptoms and zoster-associated pain. J Dermatol Sci 2013;69:243-49.","DOI":"10.1016\/j.jdermsci.2012.10.015"},{"key":"12","doi-asserted-by":"crossref","unstructured":"17) Imoto K, Okazaki A, Onishi F, Miyazaki Y, Okeda M, Yano S, Takao Y, Gomi Y, Ishikawa T, Okuno Y, Mori Y, Iso H, Yamanishi K, Asada H; SHEZ study group. VZV skin-test reaction, but not antibody, is an important predictive factor for postherpetic neuralgia. J Dermatol Sci 2015; 79:235-40.","DOI":"10.1016\/j.jdermsci.2015.05.011"},{"key":"13","doi-asserted-by":"crossref","unstructured":"18) Takahashi M, Okada S, Miyagawa H, Amo K, Yoshikawa K, Asada H, Kamiya H, Torigoe S, Asano Y, Ozaki T, Terada K, Muraki R, Higa K, Iwasaki H, Akiyama M, Takamizawa A, Shiraki K, Yanagi K, Yamanishi K. Enhancement of immunity against VZV by giving live varicella vaccine to the elderly assessed by VZV skin test and IAHA, gpELISA antibody assay. Vaccine 2003; 21:3845-53.","DOI":"10.1016\/S0264-410X(03)00303-7"},{"key":"14","doi-asserted-by":"crossref","unstructured":"19) Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weinberg A, Boardman KD, Williams HM, Zhang JH, Peduzzi PN, Beisel CE, Morrison VA, Guatelli JC, Brooks PA, Kauffman CA, Pachucki CT, Neuzil KM, Betts RF, Wright PF, Griffin MR, Brunell P, Soto NE, Marques AR, Keay SK, Goodman RP, Cotton DJ, Gnann JW Jr, Loutit J, Holodniy M, Keitel WA, Crawford GE, Yeh SS, Lobo Z, Toney JF, Greenberg RN, Keller PM, Harbecke R, Hayward AR, Irwin MR, Kyriakides TC, Chan CY, Chan IS, Wang WW, Annunziato PW, Silber JL; Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352:2271-2284.","DOI":"10.1056\/NEJMoa051016"},{"key":"15","doi-asserted-by":"crossref","unstructured":"20) Oxman MN, Levin MJ; Shingles Prevention Study Group: Vaccination against Herpes Zoster and Postherpetic Neuralgia. J Infect Dis. 2008;197 Suppl 2:S228-36.","DOI":"10.1086\/522159"},{"key":"16","doi-asserted-by":"crossref","unstructured":"21) Schmader KE, Levin MJ, Gnann JW Jr, McNeil SA, Vesikari T, Betts RF, Keay S, Stek JE, Bundick ND, Su SC, Zhao Y, Li X, Chan IS, Annunziato PW, Parrino J. Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years. Clin Infect Dis 2012; 54:922-8.","DOI":"10.1093\/cid\/cir970"},{"key":"17","doi-asserted-by":"crossref","unstructured":"23) Chlibek R, Smetana J, Pauksens K, Rombo L, Van den Hoek JA, Richardus JH, Plassmann G, Schwarz TF, Ledent E, Heineman TC. Safety and immunogenicity of three different formulations of an adjuvanted varicella-zoster virus subunit candidate vaccine in older adults: a phase II, randomized, controlled study. Vaccine 2014; 32:1745-53.","DOI":"10.1016\/j.vaccine.2014.01.019"}],"container-title":["Uirusu"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsv\/68\/1\/68_21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T03:45:41Z","timestamp":1558151141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsv\/68\/1\/68_21\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2222\/jsv.68.21","relation":{},"ISSN":["0042-6857","1884-3433"],"issn-type":[{"value":"0042-6857","type":"print"},{"value":"1884-3433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}